STAR

STRIDES PHARMA SCIENCE

Pharmaceuticals Small Cap BSE: 532531 NSE: STAR
₹335.7
-1.75 (-0.52%)
As on 04 July, 2022 | 15:23

Strides Pharma Science Share Price

Strides Pharma Science Performance

Day Range

  • Low 332
  • High 341.7

52 Week Range

  • Low 263.35
  • High 818
  • Open Price 337.45
  • Previous Close 337.45
  • Volume 326908

Strides Pharma Science Share Returns

  • Over 1 Month 1.41%
  • Over 3 Month -5.22%
  • Over 6 Month -25.44%
  • Over 1 Year -56.29%

Strides Pharma Science Key Statistics

P/E Ratio 16.7
PEG Ratio 0
Market Cap Cr 3014.7
Price to Book Ratio 379.3
EPS 20.1
Dividend 0
Relative Strength Index 55.21
Money Flow Index 71.53
MACD Signal 2.49
Average True Range 18.37

Strides Pharma Science Investment Rating

  • Master Rating:
  • Strides Pharma Science has an operating revenue of Rs. 3,070.25 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of -18% needs improvement, ROE of -19% is poor and needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 7% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 90 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev
    Qtr Cr
  • 455.66
  • 439.56
  • 575.00
  • 508.79
  • 633.60
  • Operating Expenses
    Qtr Cr
  • 437.82
  • 435.92
  • 528.03
  • 500.60
  • 545.58
  • Operating Profit
    Qtr Cr
  • 17.83
  • 3.64
  • 46.96
  • 8.19
  • 88.02
  • Depreciation
    Qtr Cr
  • 24.41
  • 26.23
  • 27.09
  • 26.64
  • 24.73
  • Interest
    Qtr Cr
  • 21.55
  • 16.60
  • 18.00
  • 18.09
  • 17.91
  • Tax
    Qtr Cr
  • -143.80
  • -14.09
  • 5.76
  • -6.56
  • 20.62
  • Net Profit
    Qtr Cr
  • 200.50
  • -17.60
  • 18.52
  • -21.23
  • 48.08

Strides Pharma Science Technicals

EMA & SMA

Current Price
333.3
-4.15 (-1.23%)
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • 324.28
  • 50 Day
  • 324.82
  • 100 Day
  • 349.71
  • 200 Day
  • 417.7
  • 20 Day
  • 320.13
  • 50 Day
  • 315.11
  • 100 Day
  • 333.28
  • 200 Day
  • 417.2

Strides Pharma Science Resistance and Support

PIVOT
₹334.17
Resistance
  • First Resistance
  • 343.29
  • Second Resistance
  • 349.12
  • Third Resistance
  • 358.24
Support
  • First Resistance
  • 328.34
  • Second Resistance
  • 319.22
  • Third Resistance
  • 313.39
  • RSI
  • 55.21
  • MFI
  • 71.53
  • MACD Single Line
  • 2.5
  • MACD
  • 5.84

Strides Pharma Science Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 674,419
  • 8,969,773
  • 13.3
  • Week
  • 2,603,876
  • 40,412,156
  • 15.52
  • 1 Month
  • 1,577,887
  • 23,968,101
  • 15.19
  • 6 Month
  • 1,095,847
  • 28,064,634
  • 25.61

Strides Pharma Science Result Highlights

Strides Pharma Science Synopsis

NSE-Medical-Generic Drugs

Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1857.57 Cr. and Equity Capital is Rs. 89.68 Cr. for the Year ended 31/03/2021. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
  • Market Cap
  • 3,015.62
  • Sales
  • 1,979.00
  • Shares in Float
  • 6.20
  • No of funds
  • 136
  • Yield
  • 0.36
  • Book Value
  • 0.89
  • U/D Vol ratio
  • 1.3
  • LTDebt / Equity
  • 4
  • Alpha
  • -0.31
  • Beta
  • 1.47

Strides Pharma Science

  • Owner Name

Strides Pharma Science Management

  • Name
  • Designation
  • Mr. Arun Kumar
  • Chairman & Non-Exe.Director
  • Dr. R Ananthanarayanan
  • Managing Director & CEO
  • Mr. Badree Komandur
  • Executive Director & Group CFO
  • Mr. Deepak Vaidya
  • Non Executive Director
  • Dr. Kausalya Santhanam
  • Independent Director
  • Mr. Bharat D Shah
  • Independent Director
  • Mr. Homi Rustam Khusrokhan
  • Independent Director
  • Mr. S Sridhar
  • Independent Director

Strides Pharma Science Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Strides Pharma Science Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-05-24
  • Audited Results & Dividend
  • 2022-02-10
  • Quarterly Results & Others
  • To consider Fund Raising (Revised) per share(45%)Dividend
  • 2021-11-10
  • Quarterly Results
  • 2021-08-06
  • Quarterly Results
  • 2021-05-27
  • Audited Results
  • Date
  • Purpose
  • Remarks
  • 2021-08-06
  • FINAL
  • Rs.2.50 per share(25%)Final Dividend

Strides Pharma Science MF Shareholding

  • Name
  • Amount(cr)
  • Kotak Equity Arbitrage Fund Growth
  • 26009.81
  • Aditya Birla Sun Life Flexi Cap Fund Growth
  • 15002.94
  • ICICI Prudential Equity Arbitrage Fund Regular Growth
  • 14409.98
  • Nippon India Arbitrage Fund Growth
  • 11068.78
  • SBI Magnum Long Term Equity Scheme Regular Payout of Income Distribution cum capital wdrl
  • 10269.4

Strides Pharma Science Similar Stocks

Company Name
Aurobindo Pharma Ltd
  • 52 week
  • 1,012.90
  • Market price
  • 528.85 (1.21%)
  • Volume
  • 36064
  • 52 week
  • 5.87
  • Market price
  • 4.70 (-4.08%)
  • Volume
  • 1000
  • 52 week
  • 1,917.00
  • Market price
  • 1,531.00 (1.84%)
  • Volume
  • 5854
Company Name
Medico Remedies Ltd
  • 52 week
  • 149.35
  • Market price
  • 85.00 (-1.79%)
  • Volume
  • 436

Strides Pharma Science News

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding request received for Loss of Share Certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding request received for Loss of Share Certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Accumulate Strides Pharma Science; target of Rs 355: Geojit

Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 355 in its research report dated June 23, 2022.

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding request received for Loss of Share Certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Strides Pharma Science FAQs

What is Share Price of Strides Pharma Science ?

Strides Pharma Science share price is ₹335 As on 04 July, 2022 | 15:09

What is the Market Cap of Strides Pharma Science ?

The Market Cap of Strides Pharma Science is ₹3014.7 As on 04 July, 2022 | 15:09

What is the P/E ratio of Strides Pharma Science ?

The P/E ratio of Strides Pharma Science is -6.5 As on 04 July, 2022 | 15:09

What is the PB ratio of Strides Pharma Science ?

The PB ratio of Strides Pharma Science is 1.3 As on 04 July, 2022 | 15:09